Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States

Rajesh Balkrishnan, Rafia S. Rasu, Rukmini Rajagopalan

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Study Objectives: This study analyzed patient and physician characteristics associated with physicians' choice of medication treatment for sleep difficulties in a nationally representative sample of outpatient physician visits in the United States. Design: Cross-sectional study of nationally representative survey data. Setting: Outpatient settings in the United States. Patients or Participants: Patients aged 18 years or older with sleep difficulty. Interventions: None. Measurements and Results: The National Ambulatory Medical Care Survey data from 1996 to 2001 were utilized. The study found that approximately 4.8 billion visits were made to outpatient physician offices in the United States, and 94.6 million of these were visits related to sleep difficulties. Visits by established patients, compared with visits by new patients, were associated with an increased prescription of some type of pharmacotherapy (odds ratio: 1.92, 95% confidence interval: 1.35-2.73). Patient visits with public insurance, as compared with private insurance, as a primary payer source were associated with increased benzodiazepine prescriptions among patients receiving pharmacotherapy (odds ratio: 1.66, 95% confidence interval: 1.13-2.45). Visits by patients aged 65 years and older, as compared with those by patients aged 18 to 34 (reference group)., had almost two times increased odds of being associated with a benzodiazepine prescription (odds ratio: 1.89, 95% confidence interval: 1.13-3.14) among patient visits receiving pharmacotherapy. Conclusions: The results of this study indicate that several patient and physician characteristics influence physician prescribing of pharmacologic treatments for sleep difficulties. The study also finds variations in pharmaceutical treatment for sleep difficulties in outpatient settings in the United States.

Original languageEnglish
Pages (from-to)715-719
Number of pages5
JournalSleep
Volume28
Issue number6
DOIs
StatePublished - 1 Jun 2005

Fingerprint

Sleep
Outpatients
Physicians
Therapeutics
Prescriptions
Odds Ratio
Confidence Intervals
Insurance
Benzodiazepines
Drug Therapy
Health Care Surveys
Physicians' Offices
Cross-Sectional Studies
Pharmaceutical Preparations

Keywords

  • Ambulatory care
  • Benzodiazepines
  • Drug therapy
  • Sleep initiation and maintenance disorders
  • Therapy

Cite this

@article{b1a3445de0de4927bb9812e80ad7f1a9,
title = "Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States",
abstract = "Study Objectives: This study analyzed patient and physician characteristics associated with physicians' choice of medication treatment for sleep difficulties in a nationally representative sample of outpatient physician visits in the United States. Design: Cross-sectional study of nationally representative survey data. Setting: Outpatient settings in the United States. Patients or Participants: Patients aged 18 years or older with sleep difficulty. Interventions: None. Measurements and Results: The National Ambulatory Medical Care Survey data from 1996 to 2001 were utilized. The study found that approximately 4.8 billion visits were made to outpatient physician offices in the United States, and 94.6 million of these were visits related to sleep difficulties. Visits by established patients, compared with visits by new patients, were associated with an increased prescription of some type of pharmacotherapy (odds ratio: 1.92, 95{\%} confidence interval: 1.35-2.73). Patient visits with public insurance, as compared with private insurance, as a primary payer source were associated with increased benzodiazepine prescriptions among patients receiving pharmacotherapy (odds ratio: 1.66, 95{\%} confidence interval: 1.13-2.45). Visits by patients aged 65 years and older, as compared with those by patients aged 18 to 34 (reference group)., had almost two times increased odds of being associated with a benzodiazepine prescription (odds ratio: 1.89, 95{\%} confidence interval: 1.13-3.14) among patient visits receiving pharmacotherapy. Conclusions: The results of this study indicate that several patient and physician characteristics influence physician prescribing of pharmacologic treatments for sleep difficulties. The study also finds variations in pharmaceutical treatment for sleep difficulties in outpatient settings in the United States.",
keywords = "Ambulatory care, Benzodiazepines, Drug therapy, Sleep initiation and maintenance disorders, Therapy",
author = "Rajesh Balkrishnan and Rasu, {Rafia S.} and Rukmini Rajagopalan",
year = "2005",
month = "6",
day = "1",
doi = "10.1093/sleep/28.6.715",
language = "English",
volume = "28",
pages = "715--719",
journal = "Sleep",
issn = "0161-8105",
publisher = "Oxford University Press",
number = "6",

}

Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States. / Balkrishnan, Rajesh; Rasu, Rafia S.; Rajagopalan, Rukmini.

In: Sleep, Vol. 28, No. 6, 01.06.2005, p. 715-719.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States

AU - Balkrishnan, Rajesh

AU - Rasu, Rafia S.

AU - Rajagopalan, Rukmini

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Study Objectives: This study analyzed patient and physician characteristics associated with physicians' choice of medication treatment for sleep difficulties in a nationally representative sample of outpatient physician visits in the United States. Design: Cross-sectional study of nationally representative survey data. Setting: Outpatient settings in the United States. Patients or Participants: Patients aged 18 years or older with sleep difficulty. Interventions: None. Measurements and Results: The National Ambulatory Medical Care Survey data from 1996 to 2001 were utilized. The study found that approximately 4.8 billion visits were made to outpatient physician offices in the United States, and 94.6 million of these were visits related to sleep difficulties. Visits by established patients, compared with visits by new patients, were associated with an increased prescription of some type of pharmacotherapy (odds ratio: 1.92, 95% confidence interval: 1.35-2.73). Patient visits with public insurance, as compared with private insurance, as a primary payer source were associated with increased benzodiazepine prescriptions among patients receiving pharmacotherapy (odds ratio: 1.66, 95% confidence interval: 1.13-2.45). Visits by patients aged 65 years and older, as compared with those by patients aged 18 to 34 (reference group)., had almost two times increased odds of being associated with a benzodiazepine prescription (odds ratio: 1.89, 95% confidence interval: 1.13-3.14) among patient visits receiving pharmacotherapy. Conclusions: The results of this study indicate that several patient and physician characteristics influence physician prescribing of pharmacologic treatments for sleep difficulties. The study also finds variations in pharmaceutical treatment for sleep difficulties in outpatient settings in the United States.

AB - Study Objectives: This study analyzed patient and physician characteristics associated with physicians' choice of medication treatment for sleep difficulties in a nationally representative sample of outpatient physician visits in the United States. Design: Cross-sectional study of nationally representative survey data. Setting: Outpatient settings in the United States. Patients or Participants: Patients aged 18 years or older with sleep difficulty. Interventions: None. Measurements and Results: The National Ambulatory Medical Care Survey data from 1996 to 2001 were utilized. The study found that approximately 4.8 billion visits were made to outpatient physician offices in the United States, and 94.6 million of these were visits related to sleep difficulties. Visits by established patients, compared with visits by new patients, were associated with an increased prescription of some type of pharmacotherapy (odds ratio: 1.92, 95% confidence interval: 1.35-2.73). Patient visits with public insurance, as compared with private insurance, as a primary payer source were associated with increased benzodiazepine prescriptions among patients receiving pharmacotherapy (odds ratio: 1.66, 95% confidence interval: 1.13-2.45). Visits by patients aged 65 years and older, as compared with those by patients aged 18 to 34 (reference group)., had almost two times increased odds of being associated with a benzodiazepine prescription (odds ratio: 1.89, 95% confidence interval: 1.13-3.14) among patient visits receiving pharmacotherapy. Conclusions: The results of this study indicate that several patient and physician characteristics influence physician prescribing of pharmacologic treatments for sleep difficulties. The study also finds variations in pharmaceutical treatment for sleep difficulties in outpatient settings in the United States.

KW - Ambulatory care

KW - Benzodiazepines

KW - Drug therapy

KW - Sleep initiation and maintenance disorders

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=20444426144&partnerID=8YFLogxK

U2 - 10.1093/sleep/28.6.715

DO - 10.1093/sleep/28.6.715

M3 - Review article

C2 - 16477958

AN - SCOPUS:20444426144

VL - 28

SP - 715

EP - 719

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 6

ER -